TXNIP and Hypercholesterolemia: PIK3C2A was notably downregulated in CAD, particularly in ACS, compared to CSA, they discovered, while TXNIP was upregulated in STEMI-ACS patients who were non-diabetic smokers with hypertension and hypercholesterolemia.